Balentine LLC’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-44,035
Closed -$646K 478
2024
Q1
$646K Buy
44,035
+1,145
+3% +$16.7K 0.02% 247
2023
Q4
$597K Buy
42,890
+9,620
+29% +$129K 0.02% 249
2023
Q3
$445K Sell
33,270
-55
-0.2% -$744 0.01% 284
2023
Q2
$421K Buy
33,325
+3,130
+10% +$36.5K 0.01% 310
2023
Q1
$344K Sell
30,195
-1,895
-6% -$20.5K 0.01% 373
2022
Q4
$332K Buy
32,090
+5,210
+19% +$56.2K 0.01% 423
2022
Q3
$281K Sell
26,880
-9,640
-26% -$103K 0.01% 410
2022
Q2
$405K Buy
36,520
+7,040
+24% +$76.5K 0.01% 359
2022
Q1
$329K Buy
+29,480
New +$334K 0.01% 404
2021
Q3
Sell
-15,720
Closed -$231K 343
2021
Q2
$231K Buy
+15,720
New +$220K 0.01% 148
2020
Q3
Sell
-9,140
Closed -$97K 693
2020
Q2
$97K Buy
+9,140
New +$93K 0.01% 155
2019
Q4
Sell
-3,290
Closed -$25K 718
2019
Q3
$25K Buy
3,290
+585
+22% +$4.35K ﹤0.01% 213
2019
Q2
$20K Buy
2,705
+595
+28% +$4.68K ﹤0.01% 210
2019
Q1
$17K Buy
2,110
+1,215
+136% +$9.23K ﹤0.01% 218
2018
Q4
$7K Hold
895
﹤0.01% 287
2018
Q3
$6K Buy
+895
New +$5.98K ﹤0.01% 313

Other funds holding RDY